Arthritis Biologics, Biosimilars, and JAK Inhibitors | Arthritis Talks
Arthritis Society Canada Arthritis Society Canada
37.7K subscribers
1,430 views
0

 Published On Nov 23, 2023

Medications provide an important option to help you treat your arthritis – yet understanding the options available and determining the right one for you can be overwhelming. The good news is that medications on the market today are safer and more effective than ever before, and for those living with inflammatory arthritis, they can slow down the progression of the disease. In this Arthritis Talks, Clinical Pharmacist Dr. Alan Low, will provide you with important information about three cutting-edge types of medications – biologics, biosimilars and Janus kinase (JAK) inhibitors. This webinar discusses:

- Similarities and differences between biologics and biosimilars
- When and where JAK inhibitors may be a suitable treatment option
- Current research related to inflammatory arthritis medications
- How to work with your healthcare provider to make informed decisions about your medications

show more

Share/Embed